布地奈德雾化吸入治疗小儿咳嗽变异性哮喘的临床分析
Clinical Analysis of Budesonide Suspension for Inhalation in the Treatment of Cough Variant Asthma in Children
-
摘要: 目的观察布地奈德雾化吸入治疗小儿咳嗽变异性哮喘(cough variant asthma,CVA)的效果.方法选择30例确诊为CVA的患儿进行为期7周的布地奈德雾化吸入治疗(0.5 mg,Bid),分别于治疗后1周、3周、5周、7周随访,记录患儿日间咳嗽均分和夜间咳嗽均分,评价治疗效果.结果治疗7周后CVA患儿临床控制26例(86.7%),部分控制4例(13.3%);治疗1周、3周、5周后患儿日间咳嗽情况均分及夜间咳嗽情况均分均逐渐降低,组间比较差异均有统计学意义(P<0.05),治疗5周后和治疗7周后咳嗽情况均分无统计学意义(P>0.05).结论布地奈德雾化吸入治疗小儿CVA可明显改善患儿咳嗽症状.Abstract: Objective To observe the effect of budesonide suspension for inhalation in the treatment of children with cough variant asthma(CVA).Methods 30 children with CVA were treated for 7 weeks with inhalation of budesonide(0.5 mg,Bid) and were followed up for 1,3,5 and 7 weeks after the treatment.The daytime and nocturnal cough score means were recorded.Results 26(86.7%)children's symptoms with CVA were controlled and 4(13.3%)children's symptoms were part of controlled after the treatment.The daytime and nocturnal...
-
Key words:
- Cough variant asthma /
- Budesonide /
- Children
点击查看大图
计量
- 文章访问数: 2368
- HTML全文浏览量: 862
- PDF下载量: 27
- 被引次数: 0